Posts

Showing posts with the label Peripheral Neuropathy Market Industry

Peripheral Neuropathy Market to Register Robust CAGR of 9 %Through 2032

  The   Peripheral Neuropathy Market Size   is expected to reach USD 7.4 Billion by 2032 at 9 % CAGR during the forecast period 2023-2032. Peripheral neuropathy is a widespread condition characterized by damage to the peripheral nerves, leading to symptoms such as pain, tingling, and weakness in the extremities. The global peripheral neuropathy market has witnessed significant growth in recent years, driven by the rising prevalence of diabetes, chemotherapy-induced neuropathy, and other medical conditions associated with nerve damage. One of the key factors contributing to the expansion of the peripheral neuropathy market is the increasing aging population globally. As individuals age, the risk of developing peripheral neuropathy rises, and this demographic trend has spurred the demand for effective treatments and management strategies. Peripheral neuropathy treatment has become a focal point in the healthcare industry, with advancements in medical research leading to the...

Peripheral Neuropathy Market Insights, Analysis, Trends and Opportunities 2023 - 2032

Peripheral Neuropathy Market The Peripheral Neuropathy Market Size is expected to reach USD 7.4 Billion by 2032 at 9 % CAGR during the forecast period 2023-2032. The extensive study for diabetic peripheral neuropathy epidemiology to discover economic treatment and expansion of peripheral nerve repair devices market can aid the peripheral neuropathy market size to increase by 2032. Damaged nerves in hands, arms, and feet due to causes, such as; chemotherapy treatments and diabetes require immediate attention. The increase in awareness about peripheral neuropathy and its therapy are innovations in the field can add impetus to the market. Major Key Players: Bristol Myers Squibb (US), Novartis AG (UK), Abbott Laboratories (US), Pfizer Inc (US), Merck and Co. Inc. (US), GlaxoSmithKline plc (UK), F. Hoffmann-La Roche Ltd. (UK), Eli Lilly and Company (US), Cipla Limited (India), Lupin Limited (India), RxFunction, Inc. (US), and Dr. Reddy's Laboratories (India) among others are ...